Eckert & Ziegler Radiopharma has reached an agreement to acquire Bioscan's radiopharmaceutical equipment business.
The transaction includes both analytical instruments used in quality assurance of radioactive pharmaceuticals and automated radiopharmaceutical synthesis units. The technology is used worldwide in the production of radiolabeled molecular imaging agents.
Terms of the transaction were not disclosed.